TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT04464200 updates: 1. completion date: 2026-07-01 → 2027-07-01 2. primary completion date: 2026-07-01 → 2027-07-01
Clinical trial NCT04464200 updates: 1. completion date: 2026-07-01 → 2027-07-01 2. primary completion date: 2026-07-01 → 2027-07-01
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical